Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Terumo Corp    4543   JP3546800008

TERUMO CORP (4543)
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( JPY)
Sales 2018 575 B
EBIT 2018 -
Net income 2018 56 412 M
Debt 2018 193 B
Yield 2018 0,99%
Sales 2019 606 B
EBIT 2019 -
Net income 2019 62 363 M
Debt 2019 151 B
Yield 2019 1,10%
P/E ratio 2018 29,02
P/E ratio 2019 26,43
EV / Sales2018 3,40x
EV / Sales2019 3,16x
Capitalization 1 762 B
More Financials
Company
Terumo Corp. engages in the manufacturing and sale of medical products and equipment.It operates through the following segments: General Hospital, Cardiac & Vascular, and Blood Management.The General Hospital segment produces, supplies, leases, and sells hospital equipment, pharmaceutical, home... 
More about the company
Surperformance© ratings of Terumo Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on TERUMO CORP
10/19 TERUMO : Revises the First-Half Results Forecast for FY 2017
10/10 TECH MAHINDRA : To set up odc for terumo bct
10/10 TERUMO : Provides Update on Impact from Hurricane Maria
09/29 TERUMO : Federal Contracts Awarded by Federal Agencies in Hawaii (Sept. 29)
09/29 TERUMO : $479,000 Federal Contract Awarded to Terumo Cardiovascular Systems
09/29 TERUMO : MILITARY $17.28 Million Federal Contract Awarded to Terumo Biotechnolog..
09/28 TERUMO : Opens a New Innovation Center in Southern California
09/27 TERUMO : MILITARY $26,829 Federal Contract Awarded to Terumo BCT
09/27 TERUMO CORP : ex-dividend day for interim dividend
09/21 TERUMO : welcomes the positive reimbursement decision for QuiremSpheres® in Belg..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
10/16DJDentsply General Counsel Exits, Marking Fourth Resignation in Recent Weeks --..
10/16DJDentsply Sirona General Counsel Exits, Marking Fourth Resignation in Recent W..
10/13 Toshiba discussing joint investment in chips with Western Digital
10/11 Mondi drags on FTSE, Provident Financial sinks
10/10 SMITH & NEPHEW : Elliott Management builds stake in Smith & Nephew - Bloomberg
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
10/19Terumo logs record interim profit on catheter sales
1
10/19Terumo : Revises the First-Half Results Forecast for FY 2017  
10/11Terumo Corp $TRUMY Stock Rating Upgraded by Zacks Investment Research  
10/10Terumo BCT Selects Windchill Quality Management to Enhance Global Quality Pro.. 
10/10PTC : Terumo BCT Selects Windchill Quality Management to Enhance Global Quali.. 
More tweets
Qtime:11
News from SeekingAlpha
2016 HAEMONETICS : Investor Patience Is Wearing Thin
2016 Terumo Corp. ADR 2017 Q2 - Results - Earnings Call Slides
2016 Abbott's Vascular Products Sale Likely Done To Address Regulatory Concerns
2016 Abbott's Vascular Tech Is Big In Japan
2016 Abbott and St. Jude to jettison vascular closure products to Terumo for $1.1B
Chart TERUMO CORP
Duration : Period :
Terumo Corp Technical Analysis Chart | 4543 | JP3546800008 | 4-Traders
Technical analysis trends TERUMO CORP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 4 970  JPY
Spread / Average Target 7,1%
EPS Revisions
Managers
NameTitle
Shinjiro Sato President, CEO & Representative Director
Takayoshi Mimura Chairman
Ryo Nishihata Chief Accounting & Financial Officer
Hiroaki Kasukawa CTO, Executive Officer, GM-Research & Development
Katsuya Takeuchi Executive Officer & Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
TERUMO CORP7.28%15 519
MEDTRONIC PLC10.18%106 457
BAXTER INTERNATIONAL43.98%34 785
ZIMMER BIOMET HOLDINGS INC16.95%24 403
C R BARD INC45.55%23 764
HOYA CORPORATION29.06%21 882